William D. Mc Combe is Chief Financial Officer of Cytek Biosciences, Inc.. Currently has a direct ownership of 55,746 shares of CTKB, which is worth approximately $186,191. The most recent transaction as insider was on Jun 02, 2025, when has been sold 35,000 shares (Common Stock) at a price of $2.78 per share, resulting in proceeds of $97,300. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 55.7K
n/a 3M change
n/a 12M change
Total Value Held $186,191

William D. McCombe Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 02 2025
BUY
Open market or private purchase
$97,300 $2.78 p/Share
35,000 Added 38.57%
55,746 Common Stock
May 19 2025
SELL
Payment of exercise price or tax liability
$35,607 $2.69 p/Share
13,237 Reduced 38.95%
20,746 Common Stock
May 19 2025
BUY
Exercise of conversion of derivative security
-
33,983 Added 58.47%
24,135 Common Stock

Also insider at

VLD
Velo3D, Inc. Technology
WDM

William D. Mc Combe

Chief Financial Officer
Campbell, CA

Track Institutional and Insider Activities on CTKB

Follow Cytek Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CTKB shares.

Notify only if

Insider Trading

Get notified when an Cytek Biosciences, Inc. insider buys or sells CTKB shares.

Notify only if

News

Receive news related to Cytek Biosciences, Inc.

Track Activities on CTKB